Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Annals of the New York Academy of Sciences|September 18, 2009
Defensins in systemic lupus erythematosusOren Froy, Zev M SthoegerHarefuah|June 21, 2002
[Behçet's disease--clinical presentation, diagnostic and therapeutic approach]Daniel Elbirt, Ilan Asher, Zev M SthoegerHarefuah|September 6, 2008
[Immune reconstitution inflammatory syndrome in human immunodeficiency (HIV) infected patients]Nancy Agmon-Levin, Daniel Elbirt, Zev M SthoegerImmunology|March 10, 2007
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of actionAmir Sharabi, Hava Azulai, Zev M Sthoeger, et al.Harefuah|April 23, 2005
[Opsoclonus myoclonus with ataxia]Ilan Asher, Daniel Elbirt, M Kushnir, et al.The Israel Medical Association Journal : IMAJ|June 30, 2006
Acute Q fever in Israel: clinical and laboratory study of 100 hospitalized patientsDavid Ergas, Avi Keysari, Victor Edelstein, et al.The American Journal of the Medical Sciences|December 19, 2008
Pulmonary arteriovenous malformation associated with necrotizing fasciitis of the thighShimon Binyamini, David Ergas, Pearl I Herskovitz, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 2006
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-betaAmir Sharabi, Heidy Zinger, Maya Zborowsky, et al.The Israel Medical Association Journal : IMAJ|July 24, 2007
The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE studyZev M Sthoeger, Abraham Eliraz, Ilan Asher, et al.Immunology|February 5, 2009
High alpha-defensin levels in patients with systemic lupus erythematosusZev M Sthoeger, Shira Bezalel, Nava Chapnik, et al.Pageof 3